RPSG Ventures Q2 FY27 Results: Consolidated Net Profit ₹115 Crore on Total Income of ₹3,252 Crore
- Earnings
- IT services and diversified holding
Reviewed byRachit TripathiBlacklitt Research
RPSG Ventures (NSE: RPSGVENT) reported consolidated total income of ₹3,252.24 crore and consolidated net profit of ₹114.54 crore for the quarter ended 30 Sep 2026, it said in a filing on 05 Nov 2026. Standalone total income was ₹91.86 crore and standalone net profit ₹1.76 crore for the same quarter.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹3,252.24 crore, up 21.5% YoY and down 9.5% QoQ
- Net profit: ₹114.54 crore, against a loss of ₹41.13 crore a year before and ₹253.09 crore in the prior quarter
- EPS: ₹26.74 basic, against a loss of ₹15.72 a year before
- Share in JV and associate profit: ₹131.19 crore, against ₹27.68 crore a year before
Standalone
The company on its own, without its subsidiaries
- Total income: ₹91.86 crore, up 29.4% YoY and 12.2% QoQ
- Net profit: ₹1.76 crore, down 12.4% YoY and up 69.2% QoQ
- EPS: ₹0.54 basic, against ₹0.60 a year before
- Finance costs: ₹28.27 crore, against ₹8.21 crore a year before
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 3,252.24 | 2,676.70 | +21.5% | 3,592.78 | -9.5% | |
| Revenue from operations | 3,243.49 | 2,668.26 | +21.6% | 3,576.44 | -9.3% |
| Other income | 8.75 | 8.44 | +3.7% | 16.34 | -46.5% |
| 114.54 | -41.13 | n/a | 253.09 | -54.7% | |
| Profit before tax | 183.59 | 10.36 | n/a | 309.94 | -40.8% |
| Finance costs | 244.22 | 210.75 | +15.9% | 242.45 | +0.7% |
| Depreciation | 131.66 | 122.73 | +7.3% | 128.14 | +2.7% |
| Tax expense | 69.05 | 51.49 | +34.1% | 56.85 | +21.5% |
| Net profit margin | 3.52% | -1.54% | +5.06 pp | 7.04% | -3.52 pp |
| EPS, basic (₹) | 26.74 | -15.72 | n/a | 27.53 | -2.9% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Operating lines moved in step with income. Revenue from operations rose 21.6% YoY, faster than other income at 3.7%, and finance costs of ₹244.22 crore equal 7.5% of total income. Tax expense of ₹69.05 crore is 37.6% of profit before tax, and the notes do not explain the rate.
Sports segment revenue fell from ₹555.17 crore in the June quarter to ₹124.87 crore. The notes say profits and losses from certain Sports transactions do not accrue evenly over the year, so its performance varies from quarter to quarter; the filing does not give a cause for this quarter's fall. The quarter before carried a ₹71.69 crore exceptional item, net, which reduced that quarter's profit before tax to ₹309.94 crore from ₹381.63 crore before it.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 91.86 | 71.00 | +29.4% | 81.84 | +12.2% | |
| Revenue from operations | 75.12 | 56.37 | +33.3% | 65.13 | +15.3% |
| Other income | 16.74 | 14.63 | +14.4% | 16.71 | +0.2% |
| 1.76 | 2.01 | -12.4% | 1.04 | +69.2% | |
| Profit before tax | 2.70 | 2.80 | -3.6% | 1.31 | +106.1% |
| Finance costs | 28.27 | 8.21 | +244.3% | 26.43 | +7.0% |
| Depreciation | 4.18 | 3.71 | +12.7% | 4.01 | +4.2% |
| Tax expense | 0.94 | 0.79 | +19.0% | 0.27 | +248.1% |
| Net profit margin | 1.92% | 2.83% | -0.92 pp | 1.27% | +0.65 pp |
| EPS, basic (₹) | 0.54 | 0.60 | -10.0% | 0.31 | +74.2% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone total income rose 29.4% YoY, with revenue from operations up 33.3%, but profit before tax fell 3.6% and net profit fell 12.4%. Finance costs of ₹28.27 crore are 30.8% of total income, against ₹8.21 crore a year before, and the filing does not give a reason for the increase.
Tax expense of ₹0.94 crore is 34.8% of profit before tax.
Inference
The filing records the acquisition of 100% of Clarionix Healthcare Private Limited, effective 25 Jun 2026, to explore healthcare opportunities, and a Composite Scheme of Arrangement for Woodlands Multispeciality Hospital Limited with an appointed date of 01 Apr 2027 that awaits approvals. The filing does not say what either will add to results, and the reason for the rise in standalone finance costs is also not given.
No dividend is mentioned in the filing, and the notes do not say whether one has been declared for the period.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
